We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise Training, Insulin Resistance and Coronary Artery Disease

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00412815
First Posted: December 18, 2006
Last Update Posted: August 28, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Hamilton Health Sciences Corporation
Canadian Diabetes Association
Information provided by (Responsible Party):
Lawson Health Research Institute
  Purpose
The purpose of this study was to determine the effects of exercise training on insulin resistance in subjects with coronary artery disease independent of changes in weight, diet, or the effect of an acute bout of exercise. We hypothesized that subjects with CAD and high normal or impaired glucose tolerance performing 12 weeks of aerobic exercise training while on a non weight-reducing diet, would have a greater decrease in insulin resistance than controls measured at 72 hours following their last bout of exercise.

Condition Intervention Phase
Coronary Artery Disease Glucose Intolerance Behavioral: Exercise training Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Other
Official Title: The Effects of Exercise Training on Insulin Resistance in Patients With Coronary Artery Disease and Insulin Resistance, the Exercise, Coronary Artery Disease and Insulin Resistance (EXCADIR) Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Insulin sensitivity

Secondary Outcome Measures:
  • Exercise capacity

Estimated Enrollment: 60
Actual Study Start Date: November 25, 1998
Study Completion Date: June 9, 2000
Primary Completion Date: June 9, 2000 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • men and women over 18 years of age
  • fasting plasma glucose concentration 5.4-7.7 mmol/L
  • confirmed CAD (diagnosed on the basis of a previous myocardial perfusion study or cardiac catheterization, or a history of a myocardial infarction or coronary artery angioplasty or coronary artery bypass surgery).

Exclusion Criteria:

  • known type 1 or 2 diabetes
  • clinical heart failure
  • uncorrected significant valvular or congenital heart disease
  • significant obstructive pulmonary disease (forced expiratory volume in 1 sec / forced vital capacity < 0.5)
  • uncontrolled hypertension (blood pressure > 220 / 120 mm Hg)
  • participation in a regular exercise program within the preceding three months
  • inability to perform exercise training, atrial fibrillation
  • a permanent pacemaker
  • regularly used corticosteroid
  • recent (< 3 months) myocardial infarction, unstable angina, coronary artery bypass graft surgery, or coronary artery angioplasty
  • run-in phase fasting blood glucose was < 5.4 mmol/L or > 11.1 mmol/L at 2 hours following the 75 gram oral glucose load.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00412815


Locations
Canada, Ontario
Hamilton Health Sciences Centre
Hamilton, Ontario, Canada, L8L2X2
Sponsors and Collaborators
Lawson Health Research Institute
Hamilton Health Sciences Corporation
Canadian Diabetes Association
Investigators
Principal Investigator: Robert S McKelvie, MD McMaster Univesrity
  More Information

Responsible Party: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00412815     History of Changes
Other Study ID Numbers: R-99-004
First Submitted: December 14, 2006
First Posted: December 18, 2006
Last Update Posted: August 28, 2017
Last Verified: August 2017

Keywords provided by Lawson Health Research Institute:
insulin sensitivity
coronary artery disease
exercise training

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Insulin Resistance
Glucose Intolerance
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Hyperglycemia
Insulin, Globin Zinc
Insulin
Hypoglycemic Agents
Physiological Effects of Drugs